Publicaciones en las que colabora con ROBERTO RODRÍGUEZ JIMÉNEZ (21)

2024

  1. Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

    Journal of Psychiatric Research, Vol. 172, pp. 334-339

2023

  1. Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

    International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807

  2. Neighborhood Vulnerability and Disability in First Episode of Psychosis: A Multilevel Study

    The Journal of clinical psychiatry, Vol. 84, Núm. 2

2022

  1. The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance

    The international journal of neuropsychopharmacology, Vol. 25, Núm. 8, pp. 666-677

  2. The relationship between negative symptoms, social cognition, and social functioning in patients with first episode psychosis

    Journal of Psychiatric Research, Vol. 155, pp. 171-179

  3. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study

    European Neuropsychopharmacology, Vol. 57, pp. 105-117

2021

  1. How does neighbourhood socio-economic status affect the interrelationships between functioning dimensions in first episode of psychosis? A network analysis approach

    Health and Place, Vol. 69

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

  2. Differences in the regulation of inflammatory pathways in adolescent- and adult-onset first-episode psychosis

    European Child and Adolescent Psychiatry, Vol. 28, Núm. 10, pp. 1395-1405

2016

  1. BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year

    Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151

2014

  1. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia

    Schizophrenia Bulletin, Vol. 40, Núm. 2, pp. 376-387

2013

  1. Peripheral endocannabinoid system dysregulation in first-episode psychosis

    Neuropsychopharmacology, Vol. 38, Núm. 13, pp. 2568-2577

2011

  1. The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia

    Schizophrenia Research, Vol. 128, Núm. 1-3, pp. 15-22

2010

  1. Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 153, Núm. 1, pp. 79-85

2009

  1. The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone

    Schizophrenia Research, Vol. 115, Núm. 2-3, pp. 215-221

2007

  1. Association in alcoholic patients between psychopathic traits and the additive effect of allelic forms of the CNR1 and FAAH endocannabinoid genes, and the 3′ region of the DRD2 gene

    Neurotoxicity Research, Vol. 11, Núm. 1, pp. 51-59

  2. Endocannabinoid system and CNR1 gene polymorphisms in schizophrenia and addictive disorders

    Actas Espanolas de Psiquiatria, Vol. 35, Núm. 2, pp. 122-129

2006

  1. (AAT)n repeat in the cannabinoid receptor gene, CNR1: Association with schizophrenia in a Spanish population

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 256, Núm. 7, pp. 437-441

  2. The TaqIA polymorphism linked to the DRD2 gene is related to lower attention and less inhibitory control in alcoholic patients

    European Psychiatry, Vol. 21, Núm. 1, pp. 66-69

2004

  1. DRD2 TaqIA polymorphism is associated with urinary homovanillic acid levels in a sample of Spanish male alcoholic patients

    Neurotoxicity Research, Vol. 6, Núm. 5, pp. 373-377